Cargando…
Serum Clusterin as a Prognostic Marker of Chronic Spontaneous Urticaria
A substantial proportion of patients with chronic spontaneous urticaria (CSU) are refractory to antihistamines. However, identifying the subpopulation whose urticaria is not completely controlled by antihistamines remains difficult. The response of autologous serum skin test (ASST), a clinical test...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902551/ https://www.ncbi.nlm.nih.gov/pubmed/27175709 http://dx.doi.org/10.1097/MD.0000000000003688 |
_version_ | 1782437018666532864 |
---|---|
author | Kim, Ji-Hye Lee, Hyung-Young Ban, Ga-Young Shin, Yoo-Seob Park, Hae-Sim Ye, Young-Min |
author_facet | Kim, Ji-Hye Lee, Hyung-Young Ban, Ga-Young Shin, Yoo-Seob Park, Hae-Sim Ye, Young-Min |
author_sort | Kim, Ji-Hye |
collection | PubMed |
description | A substantial proportion of patients with chronic spontaneous urticaria (CSU) are refractory to antihistamines. However, identifying the subpopulation whose urticaria is not completely controlled by antihistamines remains difficult. The response of autologous serum skin test (ASST), a clinical test for the detection of basophil histamine-releasing activity upon autoantibodies or autoreactive stimulation, has been suggested as a potential predictor in the control of urticaria. We sought to identify proteins that were differentially expressed in the sera of patients with positive and negative ASST results and to investigate their association with urticaria control. Proteomics analysis was performed using sera from 3 CSU patients with positive ASST results compared with those showing negative ASST results. Seven upregulated and 5 downregulated proteins were identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in the ASST-positive group compared with the ASST-negative group. Proteins that were differentially expressed according to the ASST results in CSU patients were classified into 6 groups: apolipoproteins, glycoproteins, modified albumin, haptoglobulin, plectin, and others. Among these, apolipoprotein J or clusterin was validated using an enzyme-linked immunosorbent assay. Clusterin levels in 69 ASST-positive patients were significantly higher than those in 69 ASST-negative patients and in 86 healthy controls (231.2 ± 44.0 vs 210.2 ± 36.1 vs 118.7 ± 71.9 μg/mL, P < 0.001). Furthermore, clusterin levels differed significantly between patients with responsive and refractory responses to antihistamine treatment within 3 months (231.0 ± 39.1 vs 205.1 ± 40.4 μg/mL, P < 0.001). ASST results and serum clusterin levels can predict 92.7% of CSU patients whose urticaria would be refractory to antihistamines. Serum clusterin can be a prognostic marker to determine the responsiveness to antihistamine treatment in patients with CSU. |
format | Online Article Text |
id | pubmed-4902551 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-49025512016-06-27 Serum Clusterin as a Prognostic Marker of Chronic Spontaneous Urticaria Kim, Ji-Hye Lee, Hyung-Young Ban, Ga-Young Shin, Yoo-Seob Park, Hae-Sim Ye, Young-Min Medicine (Baltimore) 3600 A substantial proportion of patients with chronic spontaneous urticaria (CSU) are refractory to antihistamines. However, identifying the subpopulation whose urticaria is not completely controlled by antihistamines remains difficult. The response of autologous serum skin test (ASST), a clinical test for the detection of basophil histamine-releasing activity upon autoantibodies or autoreactive stimulation, has been suggested as a potential predictor in the control of urticaria. We sought to identify proteins that were differentially expressed in the sera of patients with positive and negative ASST results and to investigate their association with urticaria control. Proteomics analysis was performed using sera from 3 CSU patients with positive ASST results compared with those showing negative ASST results. Seven upregulated and 5 downregulated proteins were identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in the ASST-positive group compared with the ASST-negative group. Proteins that were differentially expressed according to the ASST results in CSU patients were classified into 6 groups: apolipoproteins, glycoproteins, modified albumin, haptoglobulin, plectin, and others. Among these, apolipoprotein J or clusterin was validated using an enzyme-linked immunosorbent assay. Clusterin levels in 69 ASST-positive patients were significantly higher than those in 69 ASST-negative patients and in 86 healthy controls (231.2 ± 44.0 vs 210.2 ± 36.1 vs 118.7 ± 71.9 μg/mL, P < 0.001). Furthermore, clusterin levels differed significantly between patients with responsive and refractory responses to antihistamine treatment within 3 months (231.0 ± 39.1 vs 205.1 ± 40.4 μg/mL, P < 0.001). ASST results and serum clusterin levels can predict 92.7% of CSU patients whose urticaria would be refractory to antihistamines. Serum clusterin can be a prognostic marker to determine the responsiveness to antihistamine treatment in patients with CSU. Wolters Kluwer Health 2016-05-13 /pmc/articles/PMC4902551/ /pubmed/27175709 http://dx.doi.org/10.1097/MD.0000000000003688 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially. http://creativecommons.org/licenses/by-nc/4.0 |
spellingShingle | 3600 Kim, Ji-Hye Lee, Hyung-Young Ban, Ga-Young Shin, Yoo-Seob Park, Hae-Sim Ye, Young-Min Serum Clusterin as a Prognostic Marker of Chronic Spontaneous Urticaria |
title | Serum Clusterin as a Prognostic Marker of Chronic Spontaneous Urticaria |
title_full | Serum Clusterin as a Prognostic Marker of Chronic Spontaneous Urticaria |
title_fullStr | Serum Clusterin as a Prognostic Marker of Chronic Spontaneous Urticaria |
title_full_unstemmed | Serum Clusterin as a Prognostic Marker of Chronic Spontaneous Urticaria |
title_short | Serum Clusterin as a Prognostic Marker of Chronic Spontaneous Urticaria |
title_sort | serum clusterin as a prognostic marker of chronic spontaneous urticaria |
topic | 3600 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902551/ https://www.ncbi.nlm.nih.gov/pubmed/27175709 http://dx.doi.org/10.1097/MD.0000000000003688 |
work_keys_str_mv | AT kimjihye serumclusterinasaprognosticmarkerofchronicspontaneousurticaria AT leehyungyoung serumclusterinasaprognosticmarkerofchronicspontaneousurticaria AT bangayoung serumclusterinasaprognosticmarkerofchronicspontaneousurticaria AT shinyooseob serumclusterinasaprognosticmarkerofchronicspontaneousurticaria AT parkhaesim serumclusterinasaprognosticmarkerofchronicspontaneousurticaria AT yeyoungmin serumclusterinasaprognosticmarkerofchronicspontaneousurticaria |